Arkolith/Insider Trading/OMIC/Form 4

Glezer Eli N.

Chief Scientific OfficerSingular Genomics Systems, Inc. (OMIC) · full profile →Form 4 · filed Feb 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2025Disposed to issuer(D)156K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 21, 2025Disposed to issuer(D)2K$20.00$45K0
Feb 21, 2025Disposed to issuer(D)6K$20.00$120K0
Feb 21, 2025Disposed to issuer(D)8K—$00
Feb 21, 2025Disposed to issuer(D)17K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-027106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML